Ons laatste Nieuws

Patients have to fight to access their medicines, hit by shortages since the covid pandemic. But long supply chains aren't the only reason behind these shortages. Big Pharma has abandoned the production of old, less lucrative molecules in favour of more expensive treatments. But that profit motive is putting lives at risk.